000 | 01772 a2200505 4500 | ||
---|---|---|---|
005 | 20250517122239.0 | ||
264 | 0 | _c20170524 | |
008 | 201705s 0 0 eng d | ||
022 | _a1872-6240 | ||
024 | 7 |
_a10.1016/j.brainres.2016.10.013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLi, Dan | |
245 | 0 | 0 |
_aProtective effect of resveratrol against nigrostriatal pathway injury in striatum via JNK pathway. _h[electronic resource] |
260 |
_bBrain research _cJan 2017 |
||
300 |
_a1-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBrain Injuries, Traumatic _xcomplications |
650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xmetabolism |
650 | 0 | 4 |
_aMAP Kinase Kinase 4 _xantagonists & inhibitors |
650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeural Pathways _xdrug effects |
650 | 0 | 4 |
_aNeurodegenerative Diseases _xdrug therapy |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aResveratrol |
650 | 0 | 4 |
_aStilbenes _xpharmacology |
650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
700 | 1 | _aLiu, Nan | |
700 | 1 | _aZhao, Liang | |
700 | 1 | _aTong, Lei | |
700 | 1 | _aKawano, Hitoshi | |
700 | 1 | _aYan, Hong-Jing | |
700 | 1 | _aLi, Hong-Peng | |
773 | 0 |
_tBrain research _gvol. 1654 _gno. Pt A _gp. 1-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2016.10.013 _zAvailable from publisher's website |
999 |
_c26540113 _d26540113 |